Valuation: IDEXX Laboratories, Inc.

Market Cap 52.91B 47.24B 43.35B 39.43B 73.93B 5,009B 75.41B 518B 209B 2,644B 199B 194B 8,351B P/E 2026 *
44.7x
P/E 2027 * 40.3x
Enterprise Value 53.46B 47.73B 43.8B 39.84B 74.7B 5,061B 76.19B 523B 211B 2,671B 201B 196B 8,437B EV / Sales 2026 *
11.3x
EV / Sales 2027 * 10.3x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day+21.85%
1 week+17.79%
Current month+21.85%
1 month+29.56%
3 months+20.14%
6 months+18.36%
Current year-0.72%
1 week 540.61
Extreme 540.61
673.19
1 month 501.17
Extreme 501.17
673.19
Current year 500.61
Extreme 500.61
726.41
1 year 500.61
Extreme 500.61
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 104.21
Extreme 104.211
769.98
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO 43 2025-02-28
Chief Operating Officer 58 2024-12-31
Director TitleAgeSince
Chairman 65 2026-05-11
Director/Board Member 64 2013-07-14
Director/Board Member 73 2014-03-10
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Exercice

Director

6,609 0.0084%
8/20/26 Exercice

Chief Financial Officer

616 0.0008%
7/30/26 Free

Director

49 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+21.85%+17.79%+6.69%+60.13% 52.91B
+3.73%+5.03%-10.89%+14.80% 191B
+2.85%+4.75%+9.47%+37.73% 122B
+5.12%+0.22%-13.88%+10.27% 117B
-0.80%+2.06%-41.47%+6.49% 96.21B
+2.12%+2.38%+0.01%+75.79% 64.47B
-5.48%-5.11%-1.24%+61.88% 52.51B
+0.36%+1.13%+11.13%-22.40% 54.1B
-0.78%+4.24%+1.04%-8.32% 35.65B
+3.00%+7.88%+45.59%-9.51% 31.61B
Average +3.21%+4.27%+0.65%+22.69% 81.64B
Weighted average by Cap. +3.28%+4.10%-5.10%+22.95%

Financials

2026 *2027 *
Net sales 4.74B 4.23B 3.88B 3.53B 6.62B 449B 6.76B 46.38B 18.7B 237B 17.79B 17.41B 748B 5.16B 4.6B 4.23B 3.84B 7.21B 488B 7.35B 50.47B 20.34B 258B 19.36B 18.94B 814B
Net income 1.2B 1.07B 981M 893M 1.67B 113B 1.71B 11.72B 4.72B 59.84B 4.49B 4.4B 189B 1.31B 1.17B 1.07B 977M 1.83B 124B 1.87B 12.83B 5.17B 65.52B 4.92B 4.82B 207B
Net Debt 547M 489M 448M 408M 765M 51.82B 780M 5.36B 2.16B 27.35B 2.05B 2.01B 86.39B 193M 173M 158M 144M 270M 18.31B 276M 1.89B 763M 9.66B 726M 710M 30.52B
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
26-11-02 US$671.64 +21.85% 1,977,313
26-10-30 US$551.21 -4.30% 1,174,194
26-10-29 US$575.98 +2.32% 479,539
26-10-28 US$562.91 +0.30% 351,839
26-10-27 US$561.25 -1.57% 488,986
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
671.64USD
Average target price
694.83USD
Spread / Average Target
+3.45%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IDEXX Laboratories, Inc.
  1. Stock Market
  2. Stocks
  3. IDXX Stock